News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, August 13th at 8:30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients
Jaguar Health plans crofelemer approval pathway for breast and lung cancer based on phase 3 results. Join the investor webcast on August 13, 2024, for financial & corporate updates -
-
COMMUNIQUÉ DE PRESSE
Artmarket.com: 2Q2024 in double-digit growth, Artprice, in a 2024 study, ranks as the 'top-of-mind' data bank on the art market and opens up to the online global higher education market in line
The 36th CIHA Congress in Lyon (2024) gathered 2,000 delegates and 1,000 speakers from 70 countries. Artprice by Artmarket, a principal patron, conducted a study on its notoriety among attendees showing impressive results -
-
